Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19

AMERICAN JOURNAL OF HEMATOLOGY

WILEY

1. COVID 3 x 1 project, BREMBO S.p.A., Bergamo, Italy
2. AIRC [21267]
3. HARMONY PLUS through the Innovative Medicines Initiative (IMI)
4. IMI 2 Joint Undertaking [945406]
5. European Union's Horizon 2020 Research and Innovation Programme
6. European Federation of Pharmaceutical Industries and Associations (EFPIA)